Barry J. Simon , Director at ImmunityBio, holds 3.12M shares in ImmunityBio (Ticker: IBRX), holds ― shares in Cue Biopharma (Ticker: CUE), holds ― shares in Viracta Therapeutics (Ticker: VIRX).
What is the percentage of profitable transactions made by Barry J. Simon ?
The percentage of profitable transactions made by Barry J. Simon is 50%.
What is the average return per transaction made by Barry J. Simon ?
The average return per transaction made by Barry J. Simon is 35.90%.
What stocks does Barry J. Simon hold?
Barry J. Simon holds: IBRX, CUE, VIRX stocks.
What was Barry J. Simon ’s latest transaction?
Barry J. Simon latest transaction was an Uninformative Buy of $74.24K.
What was Barry J. Simon 's most profitable transaction?
Barry J. Simon ’s most profitable transaction was an Informative Sell of IBRX stock on May 25, 2021. The return on the trade was 77.70%.
What is Barry J. Simon 's role in ImmunityBio?
Barry J. Simon 's role in ImmunityBio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.